EP3433256
6,7,8,9-tetrahýdró-3H-pýrasóló[4,3-f]ísókínólín-afleiða sem er nytsamleg við meðhöndlun á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.10.2017EP published:
7.8.2019EP application number:
17783857.0
EP translation filed:
24.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
12.10.2037Expiry date:
12.10.2026Next due date:
31.10.2026
Title:
6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINE DERIVATIVE USEFUL IN THE TREATMENT OF CANCER
Timeline
Today
13.10.2017EP application
7.8.2019EP Publication
24.10.2019Translation submitted
15.11.2019Registration published
12.10.2026Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
SCOTT, James, StewartAddress:
CambridgeCambridgeshire CB4 0WG, GB
Name:
BARLAAM, Bernard, ChristopheAddress:
CambridgeCambridgeshire CB4 0WG, GB
Name:
YANG, BinAddress:
Waltham, MA, US
Name:
MOSS, Thomas, AndrewAddress:
CambridgeCambridgeshire CB4 0WG, GB
Name:
HUGHES, Samantha, JayneAddress:
CambridgeCambridgeshire CB4 0WG, GB
Name:
NISSINK, Johannes, Wilhelmus, MariaAddress:
CambridgeCanbridgeshire CB4 0WG, GB
Name:
O'DONOVAN, Daniel, HillebrandAddress:
CambridgeCambridgeshire CB4 0WG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662411799 PDate:
24.10.2016Country:
US
Number:
201662435159 PDate:
16.12.2016Country:
US
Classification
Categories:
C07D 471/04, A61K 31/4738, A61K 31/497, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 7.10.2019
Expires: 12.10.2020
Payer: Árnason Faktor
Number: 4
Paid: 9.9.2020
Expires: 12.10.2021
Payer: Árnason Faktor ehf.
Number: 5
Paid: 7.9.2021
Expires: 12.10.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 7.9.2022
Expires: 12.10.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 13.10.2023
Expires: 12.10.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 17.9.2024
Expires: 12.10.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 14.10.2025
Expires: 12.10.2026
Payer: Árnason Faktor ehf.